Web Extras

"Opening Doors"

The DarDar Health Project is a collaboration between Dartmouth Medical School and Muhimbili University College of Health Sciences (MUCHS) in Dar es Salaam, Tanzania. The project began in 2000 as a clinical trial of an experimental tuberculosis (TB) vaccine in Tanzanians with HIV. TB is a main cause of death in HIV/AIDS patients worldwide. DarDar now encompasses a primary-care clinic for patients enrolled in the trial; a clinic for their children; a training grant underwritten by the U.S. National Institutes of Health that allows MUCHS faculty to earn degrees at DMS; faculty and student exchanges; and more.

For more on the project see the feature "Opening Doors"

Images

Scenes of Dar es Salaam, Tanzania
(Photographs by Patrick J. Saine)

Video

The DarDar Health Project in Tanzania
(Videography by Daniel Kaser)

• Dr. Lillian Mtei
  Clinical Coordinator, DarDar Health Project
  
  
  • What is the purpose of the DarDar study?
    
    
    
• Dr. C. Fordham von Reyn
  Director, DarDar Health Project
  Professor of Medicine, DMS
  
  
  • Why study TB in patients with HIV?
  • How do patients benefit from the study?
  • Isn't there already a TB vaccine?
    
    
    
• Patient at the DarDar Clinic
  
  
  • Why did you enroll in the DarDar study?
  • Were there other reasons you joined this study?
    
    
    
• A visit to the DarDar Clinic
  
  
  • Medium Version
  • Large Version

See all for this issue

If you'd like to offer feedback about this article, we'd welcome getting your comments at DartMed@Dartmouth.edu.

This article may not be reproduced or reposted without permission. To inquire about permission, contact DartMed@Dartmouth.edu.